skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease

(2954) Views  (596) Full article downloads

Authors: Arpad Z Barabas, Chad D Cole, Arpad D Barabas, Rene Lafreniere

Published Date October 2007 Volume 2007:1(1) Pages 59 - 68
DOI: http://dx.doi.org/10.2147/BTT.S

Arpad Z Barabas1, Chad D Cole2, Arpad D Barabas1, Rene Lafreniere1

1Department of Surgery, University of Calgary Health Sciences Centre, Calgary, Alberta, Canada; 2Department of Neurosurgery, University of Utah, Salt Lake City, Utah, USA

Abstract: We describe a new vaccination method called modified vaccination technique (MVT). The technique is able to achieve downregulation of pathogenic autoimmune events leading to a chronic progressive disorder in rats called slowly progressive Heymann nephritis. Downregulation of immunopathological events is achieved by injections of immune complex (IC) made up of the target native antigen (ag) and specific naturally occurring immunoglobulin M (IgM) antibody (ab) directed against it. Repeated injections of IC maintain high levels of specific circulating IgM autoantibodies (aabs) against the kidney ag. The developing physiologic IgM aabs assist in the catabolism of both modified and unmodified renal ags from the circulation. No disease-causing renal ags in the circulation results in no stimulation of pathogenic immunoglobulin G aab producing cell lines. Such specific targeted therapy leads to termination of disease-causing processes and reestablishment of tolerance. The MVT can be employed both prophylactically and therapeutically with equal effectiveness. A redirected immune response is achieved by specifically stimulating the animals’ own IgM-producing cell lines with the injected ICs, resulting in a natural cure. Such ICs are nontoxic and nonirritant and cause no side effects. We surmise that the MVT, employing the appropriate components in each instance, can also be used to treat human ailments.

Keywords: antibody information transfer; autoimmune disease; immune complex; modified vaccination technique; prophylactic; therapeutic








Readers of this article also read:

α-L-iduronidase therapy for mucopolysaccharidosis type I
Analysis and variability of TGFβ measurements in cancer patients with skeletal metastases
T20QoL: an observational multicenter cohort study to evaluate the quality of life in HIV-patients treated with enfuvirtide (ENF, T-20) in combination with an optimized background therapy
Gamma knife radiosurgery for uveal melanoma ineligible for brachytherapy by the Collaborative Ocular Melanoma Study criteria
Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy
Growth hormone and aging: A challenging controversy
Therapeutic vaccines for malignant brain tumors
Periosteoplasty for covering gingival recessions: Clinical results
Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers
International advocacy against DDT and other public health insecticides for malaria control
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • Journal Indexing

    See where all the Dove Press journals are indexed